RM vs WST · P/E 7.5, rev $588.5M vs P/E 35, rev $2.89B
Regional Management Corp (RM) versus West Pharmaceutical Services Inc (WST) — a side-by-side from cached financials, not a winner call.
Regional Management Corp (RM) is a credit services company listed on NYSE.
West Pharmaceutical Services Inc (WST) is a medical instruments & supplies company listed on US.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Latest reported WST revenue for 2024-12-31 was $2.89B. Net income was $492.7M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. WST currently screens at market cap $15.97B and trailing P/E 34.8.
RM currently screens at market cap $339.8M and trailing P/E 7.5. WST currently screens at market cap $15.97B and trailing P/E 34.8.
Not investment advice. Open the RM and WST stock pages for the full models.
Not investment advice.